{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:53:22Z","timestamp":1770836002536,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12866-015-0458-9","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T02:45:54Z","timestamp":1434336354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014\u2009\u2013\u20092015"],"prefix":"10.1186","volume":"15","author":[{"given":"Anand","family":"Deshmukh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferry","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola Al","family":"Sharabasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariamma","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godwin","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Doiphode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna Al","family":"Maslamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques F","family":"Meis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"458_CR1","first-page":"\u115f","volume-title":"Fact sheet N173","author":"World Health Organization (WHO)","year":"1997","unstructured":"World Health Organization (WHO). Fact sheet N173. Geneva, Switzerland: WHO; 1997 :\u115f."},{"key":"458_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.vetmic.2009.06.021","volume":"140","author":"MN Seleem","year":"2010","unstructured":"Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010;140:392\u20138.","journal-title":"Vet Microbiol"},{"key":"458_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","volume":"6","author":"G Pappas","year":"2006","unstructured":"Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91\u20139.","journal-title":"Lancet Infect Dis"},{"key":"458_CR4","unstructured":"Corbel MJ. Brucellosis in humans and animals. Geneva (Switzerland): World Health Organization; 2006."},{"key":"458_CR5","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1086\/421024","volume":"38","author":"S Robichaud","year":"2004","unstructured":"Robichaud S, Libman M, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis. 2004;38:e119\u201322.","journal-title":"Clin Infect Dis"},{"key":"458_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1471-2180-11-267","volume":"11","author":"F Lista","year":"2011","unstructured":"Lista F, Reubsaet FA, De Santis R, Parchen RR, de Jong AL, Kieboom J, et al. Reliable identification at the species level of Brucella isolates with MALDI-TOF-MS. BMC Microbiol. 2011;11:267.","journal-title":"BMC Microbiol"},{"key":"458_CR7","volume-title":"Methods of antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved guidelines- second edition. CLSI document M45-A2","author":"CLSI","year":"2010","unstructured":"CLSI. Methods of antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved guidelines- second edition. CLSI document M45-A2. Wayne, PA: Clinical and Laboratory Standard Institute; 2010."},{"key":"458_CR8","volume-title":"Performance standard for antimicrobial susceptibility testing: twenty-fourth informational supplement. CLSI document M100-S24","author":"CLSI","year":"2014","unstructured":"CLSI. Performance standard for antimicrobial susceptibility testing: twenty-fourth informational supplement. CLSI document M100-S24. Wayne, PA: Clinical and Laboratory Standard Institute; 2014."},{"key":"458_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-0711-11-24","volume":"11","author":"M Abdel-Maksoud","year":"2012","unstructured":"Abdel-Maksoud M, House B, Wasfy M, Abdel-Rahman B, Pimentel G, Roushdy G, et al. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Ann Clin Microbiol Antimicrob. 2012;11:24.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"458_CR10","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1128\/JCM.42.12.5439-5443.2004","volume":"42","author":"C Marianelli","year":"2004","unstructured":"Marianelli C, Ciuchini F, Tarantino M, Pasquali P, Adone R. Genetic bases of the rifampicin resistance phenotype in Brucella spp. J Clin Microbiol. 2004;42:5439\u201343.","journal-title":"J Clin Microbiol"},{"key":"458_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jac\/dkp389","volume":"65","author":"S Valdezate","year":"2010","unstructured":"Valdezate S, Navarro A, Medina-Pascual MJ, Carrasco G, Sa\u00e9z-Nieto JA. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis. J Antimicrob Chemother. 2010;65:51\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"458_CR12","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/AAC.43.9.2337","volume":"43","author":"D G\u00fcr","year":"1999","unstructured":"G\u00fcr D, Kocag\u00f6z S, Akova M, Unal S. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis. Antimicrob Agents Chemother. 1999;43:2337.","journal-title":"Antimicrob Agents Chemother"},{"key":"458_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7150\/ijms.8.198","volume":"8","author":"Y Bayram","year":"2011","unstructured":"Bayram Y, Korkoca H, Aypak C, Parlak M, Cikman A, Kilic S, et al. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens. Int J Med Sci. 2011;8:198\u2013202.","journal-title":"Int J Med Sci"},{"key":"458_CR14","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1128\/JCM.00822-07","volume":"45","author":"C Marianelli","year":"2007","unstructured":"Marianelli C, Graziani C, Santangelo C, Xibilia MT, Imbriani A, Amato R, et al. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy. J Clin Microbiol. 2007;45:2923\u20138.","journal-title":"J Clin Microbiol"},{"key":"458_CR15","doi-asserted-by":"publisher","first-page":"596245","DOI":"10.1155\/2014\/596245","volume":"2014","author":"R Hashim","year":"2014","unstructured":"Hashim R, Ahmad N, Mohamed Zahidi J, Tay BY, Mohd Noor A, Zainal S, et al. Identification and in vitro antimicrobial susceptibility of Brucella species isolated from human brucellosis. Int J Microbiol. 2014;2014:596245.","journal-title":"Int J Microbiol"},{"key":"458_CR16","first-page":"145","volume":"42","author":"O Kaya","year":"2012","unstructured":"Kaya O, Ak\u00e7am FZ, Yayl\u0131 G. Investigation of the in vitro activities of various antibiotics against Brucella melitensis strains. Turk J Med Sci. 2012;42:145\u20138.","journal-title":"Turk J Med Sci"},{"key":"458_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/00365540410020767","volume":"36","author":"A L\u00f3pez-merino","year":"2004","unstructured":"L\u00f3pez-merino A, Contreras-rodr\u00edguez A, Migranas-ortiz R, Orrantia-grad\u00edn R, Hern\u00e1ndez-oliva GM, Torres Y, et al. Susceptibility of Mexican Brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. Scand J Infect Dis. 2004;36:636\u20138.","journal-title":"Scand J Infect Dis"},{"key":"458_CR18","doi-asserted-by":"publisher","first-page":"e32090","DOI":"10.1371\/journal.pone.0032090","volume":"7","author":"J Sol\u00eds Garc\u00eda del Pozo","year":"2012","unstructured":"Sol\u00eds Garc\u00eda del Pozo J, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One. 2012;7:e32090.","journal-title":"PLoS One"},{"key":"458_CR19","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1371\/journal.pmed.0040317","volume":"4","author":"J Ariza","year":"2007","unstructured":"Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007;4:e317.","journal-title":"PLoS Med"},{"key":"458_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jinf.2006.09.015","volume":"54","author":"G Pappas","year":"2007","unstructured":"Pappas G, Siozopoulou V, Akritidis N, Falagas ME. Doxycycline-rifampicin: physicians\u2019 inferior choice in brucellosis or how convenience reigns over science. J Infect. 2007;54:459\u201362.","journal-title":"J Infect"},{"key":"458_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/bmj.39497.500903.25","volume":"336","author":"K Skalsky","year":"2008","unstructured":"Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008;336:701\u20134.","journal-title":"BMJ"},{"key":"458_CR22","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1128\/AAC.38.12.2798","volume":"38","author":"JD Colmenero","year":"1994","unstructured":"Colmenero JD, Fernandez-Gallardo LC, Agundez JA, Sedeno J, Benitez J, Valverde E. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis. Antimicrob Agents Chemother. 1994;38:2798\u2013802.","journal-title":"Antimicrob Agents Chemother"},{"key":"458_CR23","volume-title":"Kucers\u2019 the use of antibiotics a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs","author":"ML Grayson","year":"2010","unstructured":"Grayson ML, Kucers A. Kucers\u2019 the use of antibiotics a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 6th ed. London: Hodder Arnold; 2010.","edition":"6"},{"key":"458_CR24","first-page":"25","volume":"1","author":"AI Rahil","year":"2014","unstructured":"Rahil AI, Othman M, Ibrahim W, Mohamed MY. Brucellosis in Qatar: a retrospective cohort study. Qatar Med J. 2014;1:25.","journal-title":"Qatar Med J"},{"key":"458_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/ja.2014.107","volume":"67","author":"BP Goldstein","year":"2014","unstructured":"Goldstein BP. Resistance to rifampicin: a review. J Antibiot (Tokyo). 2014;67:625\u201330.","journal-title":"J Antibiot (Tokyo)"},{"key":"458_CR26","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1021\/pr201122w","volume":"11","author":"V Sandalakis","year":"2012","unstructured":"Sandalakis V, Psaroulaki A, De Bock PJ, Christidou A, Gevaert K, Tsiotis G, et al. Investigation of rifampicin resistance mechanisms in Brucella abortus using MS-driven comparative proteomics. J Proteome Res. 2012;11:2374\u201385.","journal-title":"J Proteome Res"},{"key":"458_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10156-011-0281-7","volume":"18","author":"M Sayan","year":"2012","unstructured":"Sayan M, Kilic S, Uyanik MH. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey. J Infect Chemother. 2012;18:41\u20136.","journal-title":"J Infect Chemother"},{"key":"458_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00006454-198901001-00025","volume":"8","author":"MM Lubani","year":"1989","unstructured":"Lubani MM, Dudin KI, Sharda DC, Ndhar DS, Araj GF, Hafez HA, et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. 1989;8:75\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"458_CR29","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/AAC.43.6.1531","volume":"43","author":"A Kinsara","year":"1999","unstructured":"Kinsara A, Al-Mowallad A, Osoba AO. Increasing resistance of Brucellae to co-trimoxazole. Antimicrob Agents Chemother. 1999;43:1531.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl D","key":"458_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/18.Supplement_D.43","volume":"18","author":"CS Easmon","year":"1986","unstructured":"Easmon CS, Crane JP, Blowers A. Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies. J Antimicrob Chemother. 1986;18(Suppl D):43\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"458_CR31","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.43.5.1298","volume":"43","author":"M Akova","year":"1999","unstructured":"Akova M, Gur D, Livermore DM, Kocagoz T, Akalin HE. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob Agents Chemother. 1999;43:1298\u2013300.","journal-title":"Antimicrob Agents Chemother"},{"key":"458_CR32","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1469-0691.2006.01442.x","volume":"12","author":"G Pappas","year":"2006","unstructured":"Pappas G, Christou L, Akritidis N, Tsianos EV. Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect. 2006;12:823\u20135.","journal-title":"Clin Microbiol Infect"},{"key":"458_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1128\/AAC.50.1.22-33.2006","volume":"50","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother. 2006;50:22\u201333.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12866-015-0458-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-015-0458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-015-0458-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-015-0458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:43:31Z","timestamp":1551185011000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-015-0458-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1186\/s12866-015-0458-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]},"assertion":[{"value":"3 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"121"}}